Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization

Human Pathology

Volumn 40, Issue 2, 2009, Pages 211-217

  Wang, Xiaoyan ^a   MacLennan, Gregory T ^b   Zhang, Shaobo ^a   Montironi, Rodolfo ^c   Lopez Beltran, Antonio ^d   Tan, Puay Hoon ^e   Foster, Stephanie ^a   Baldridge, Lee Ann ^a   Cheng, Liang ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF CÓRDOBA   (Spain)

^e SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Biomarkers; Bladder; Fluorescence in situ hybridization; Prognosis; Sarcomatoid carcinoma; Upper urinary tract; Ureter

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53; STEM CELL FACTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOSARCOMA; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9P; CLINICAL ARTICLE; FEMALE; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY MASS; LYMPH NODE METASTASIS; MALE; MOLECULAR BIOLOGY; NEPHROURETERECTOMY; PROGNOSIS; SEPSIS; TREATMENT OUTCOME; TUMOR VOLUME; URINARY TRACT CARCINOMA; URINARY TRACT OBSTRUCTION; UROGENITAL TRACT TUMOR;

AGED; CARCINOMA; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UROLOGIC NEOPLASMS;

EID: 58149134052     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.07.003     Document Type: Article

References (28)

1. Bonsib S.M., and Cheng L. Renal pelvis and ureter. In: Bostwock D.G., and Cheng L. (Eds). Urilogic surgical pathology. 2nd ed. (2008), Elsevier/Mosby, New York 173-194
2. Johnin K., Kadowaki T., Kushima M., et al. Primary heterologous carcinosarcoma of the ureter with necrotic malignant polyps. Report of a case and review of the literature. Urol Int 70 (2003) 232-235
3. Yano S., Arita M., Ueno F., et al. Carcinosarcoma of the ureter. Eur Urol 10 (1984) 71
4. Piscioli F., Bondi A., Scappini P., et al. "True" sarcomatoid carcinoma of the renal pelvis. First case report with immunocytochemical study. Eur Urol 10 (1984) 350-355
5. Vermeulen P., Hoekx L., Colpaert C., et al. Biphasic sarcomatoid carcinoma (carcinosarcoma) of the renal pelvis with heterologous chondrogenic differentiation. Virchows Arch 437 (2000) 194-197
6. Tarry W.F., Morabito R.A., and Belis J.A. Carcinosarcoma of the renal pelvis with extension into the renal vein and inferior vena cava. J Urol 128 (1982) 582-585
7. Darko A., Das K., Bhalla R.S., et al. Carcinosarcoma of the ureter: report of a case with unusual histology and review of the literature. Int J Urol 13 (2006) 1528-1531
8. Perimenis P., Athanasopoulos A., Geragthy J., et al. Carcinosarcoma of the ureter: a rare, pleomorphic, aggressive malignancy. Int Urol Nephrol 35 (2003) 491-493
9. Nagayoshi J., Kawakami T., and Maruyama Y. Sarcomatoid carcinoma of the ureter: a case report. Int J Urol 4 (1997) 618-620
10. Lee G., Rankin A., Williamson M., et al. Sarcomatoid carcinoma arising from the ureter: a rare case and a treatment dilemma. Int Urol Nephrol 36 (2004) 153-154
11. Sung M.T., Wang M., Mclennan G., et al. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol 211 (2007) 420-430
12. Busby J.E., Brown G.A., Tamboli P., et al. Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology 67 (2006) 518-523
13. Wang X., Jones T.D., Zhang S., et al. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Mod Pathol 20 (2007) 175-182
14. Wang X., Zhang S., MacLennan G.T., et al. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res 13 (2007) 953-957
15. Jones T.D., Zhang S., Lopez-Beltran A., et al. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in-situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 31 (2007) 1861-1867
16. Wolff A.C., Hammond M.E., Schwartz J.N., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25 (2007) 118-145
17. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164 (2000) 1768-1775
18. Sarosdy M.F., Schellhammer P., Bokinsky G., et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168 (2002) 1950-1954
19. Smith N.D., Rubenstein J.N., Eggener S.E., et al. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. J Urol 169 (2003) 1219-1228
20. Cohen S., Ushiro H., Stoscheck C., et al. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biol Chem 257 (1982) 1523-1531
21. Hirsch F.R., Varella-Garcia M., Bunn Jr. P.A., et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21 (2003) 3798-3807
22. Ooi A., Takehana T., Li X., et al. Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study. Mod Pathol 17 (2004) 895-904
23. Hirsch F.R., Scagliotti G.V., Langer C.J., et al. Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. Lung Cancer 41 Suppl 1 (2003) S29-S42
24. Cheng L., and Zhang D. Molecular genetic pathology (2008), Humana Press/Springer, Totowa, NH
25. Yamamoto T., Ikawa S., Akiyama T., et al. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319 (1986) 230-234
26. Slamon D.J., Godolphin W., Jones L.A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
27. Onn A., Correa A.M., Gilcrease M., et al. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 10 (2004) 136-143
28. Antonescu C.R. Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas. Mod Pathol 21 Suppl 2 (2008) S31-S36